Research Paper Volume 13, Issue 13 pp 17638—17654
Pretreatment neutrophil-to-lymphocyte ratio predicts the benefit of gastric cancer patients with systemic therapy
Figure 2. Forest plot for the hazard ratios (HRs) of overall survival (OS) in gastric cancer patients with systemic therapy between low and high pretreatment NLR. “D+L” means DerSimonian and Laird method. “I-V” means generic inverse variance method.